8691 Recovery Of Adrenal Function After Stopping Mitotane In Patients With Adrenocortical Carcinoma
8691 Recovery Of Adrenal Function After Stopping Mitotane In Patients With Adrenocortical Carcinoma
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Disclosure: B. Altieri: None. O. Kimpel: None. F. Megerle: None. M. Detomas: None. I.O. Chifu: None. C.T. Fuss: None. M. Quinkler: None. M. Kroiss: None. M. Fassnacht: None.
Background: Mitotane is the standard therapy of adrenocortical carcinoma (ACC), both adjuvantly in patients with high risk of recurrence and palliative setting,...
Alternative Titles
Full title
8691 Recovery Of Adrenal Function After Stopping Mitotane In Patients With Adrenocortical Carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11454633
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11454633
Other Identifiers
ISSN
2472-1972
E-ISSN
2472-1972
DOI
10.1210/jendso/bvae163.282
